2015
DOI: 10.1016/j.bmc.2015.06.019
|View full text |Cite
|
Sign up to set email alerts
|

BN/CC isosterism in borazaronaphthalenes towards phosphodiesterase 10A (PDE10A) inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
29
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 64 publications
(29 citation statements)
references
References 34 publications
0
29
0
Order By: Relevance
“…Kilburn has likewise generated a series of BN-naphthalene derivatives to test as inhibitors of phosphodiesterase 10A (PDE10A), an enzyme localized in human brain tissue and a target for treatment of various neurological diseases. 43 Two members of the series ( 21 and 22 ) displayed markedly greater activity against PDE10A than their all-carbon equivalents (although quinoline-based variants proved the most potent overall) (Table 4). While these results, in conjunction with those reported by Zécri and Liu ( vide supra ), are indeed encouraging, much further study is likely required before BN-isosterism becomes a standard tool of drug discovery efforts.…”
Section: 2-bn-naphthalenesmentioning
confidence: 99%
“…Kilburn has likewise generated a series of BN-naphthalene derivatives to test as inhibitors of phosphodiesterase 10A (PDE10A), an enzyme localized in human brain tissue and a target for treatment of various neurological diseases. 43 Two members of the series ( 21 and 22 ) displayed markedly greater activity against PDE10A than their all-carbon equivalents (although quinoline-based variants proved the most potent overall) (Table 4). While these results, in conjunction with those reported by Zécri and Liu ( vide supra ), are indeed encouraging, much further study is likely required before BN-isosterism becomes a standard tool of drug discovery efforts.…”
Section: 2-bn-naphthalenesmentioning
confidence: 99%
“…9 More recently, BN isosteres of naphthalene have been profiled in vitro and in vivo in terms of biological activity and ADME (absorption, distribution, metabolism, excretion) properties. 10,11 …”
mentioning
confidence: 99%
“…More recently, through isothermal titration calorimetry and protein crystal structure analysis, we have demonstrated the increased binding strength of benzene and ethylbenzene BN-analogues in the polar binding pocket of T4 lysozyme mutants through a hydrogen bonding interaction unavailable in the carbonaceous compounds 6. As a pharmacophore in medicinal chemistry, BN analogues of naphthalene-containing biologically active compounds have been studied through ADMET (absorption, distribution, metabolism, excretion, toxicity) and biological activity profiling, both in vivo and in vitro 8,9. We have shown, also through ADMET profiling, that the 1,2-azaborine analogues of biologically active compounds can increase the bioavailability of the drug without significantly altering the activity of the all-carbon substrate 10.…”
Section: Introductionmentioning
confidence: 99%